Spire Healthcare GroupCHIX:SPIL 75 EV-to-FCF is 13.14 as of Jun. 27, 2026, which is 24% below its 10-year median of 17.30. GuruFocus rates CHIX:SPIL with a GF Score™ of 75/100 and a GF Value™ of £2.70 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Spire Healthcare Group ranks better than 59.76% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Spire Healthcare Group's Enterprise Value is £2,151 Mil.
Spire Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £164 Mil. Therefore, Spire Healthcare Group's EV-to-FCF for today is 13.14.
The historical rank and industry rank for Spire Healthcare Group's EV-to-FCF or its related term are showing as below:
CHIX:SPIl'
s EV-to-FCF Range Over the Past 10 Years
Min: 9.14 Med: 17.3 Max: 378.64
Current: 13.12
During the past 13 years, the highest EV-to-FCF of Spire Healthcare Group was 378.64. The lowest was 9.14. And the median was 17.30.
CHIX:SPIl's EV-to-FCF is ranked better than 59.76% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs CHIX:SPIl: 13.12
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spire Healthcare Group (CHIX:SPIl) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spire Healthcare Group's PE Ratio (TTM) for today is calculated as:
Spire Healthcare Group's share price for today is £2.185.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Spire Healthcare Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's EV-to-FCF falls into.
Spire Healthcare Group's current Enterprise Value is £2,151 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £164 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group (CHIX:SPIL) has a EV-to-FCF of 13.14 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Spire Healthcare Group and its competitors. This is 24% below median its historical median of 17.30. Over the past decade, Spire Healthcare Group's EV-to-FCF has ranged from 9.14 to 378.64. According to the industry distribution chart, Spire Healthcare Group ranks #165 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 40.2%.
Is Spire Healthcare Group's EV-to-FCF too high?
Spire Healthcare Group's current EV-to-FCF of 13.14 is 24% below median its 10-year median of 17.30. Over the past 10 years, this metric has ranged from a low of 9.14 to a high of 378.64. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. Spire Healthcare Group's value of 13.14 is 24.6% below this industry median. Based on the distribution chart, Spire Healthcare Group ranks #165 out of 410 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #165 out of 410 companies for EV-to-FCF. This puts Spire Healthcare Group in the upper half of its industry. The industry median EV-to-FCF is 17.44. Spire Healthcare Group's value of 13.14 is 24.6% below this benchmark. Historically, Spire Healthcare Group's own EV-to-FCF has ranged from 9.14 to 378.64 over the past decade. While the company's 10-year median is 17.30 vs. the industry median of 17.44, Spire Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current EV-to-FCF of 13.14 is 24.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current EV-to-FCF is 13.14, which is 24% below median its own 10-year median of 17.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.70, compared to a current price of £2.19 — trading 19.1% below its estimated fair value. The current EV-to-FCF is 13.14, which is 24% below median its 10-year median of 17.30 and 24.6% below the Healthcare Providers & Services industry median of 17.44. Spire Healthcare Group's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current EV-to-FCF is 13.14 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.19 is trading 19.1% below its estimated GF Value™ of £2.70.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
EV-to-FCF: 13.14 (24% below median its 10-year median of 17.30)
GF Value™: £2.70 vs. price of £2.19 (19.1% below fair value)
Industry Position: 24.6% below the Healthcare Providers & Services median (#165 of 410)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
75GF Score
Get the complete analysis for CHIX:SPIL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
